Lupin Healthcare (UK) Limited

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2026	2	Value not published	2
2025	1	Value not published	1
2024	3	Value not published	3
2023	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierLupin Healthcare (UK) Limited

Source records

Published awards

17 records linked to this supplier.

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
Buyer: NHS England
End date in notice
30 Apr 2029
Value shown in notice
£1,241,520,444Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60 / ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60-1
NHS National Branded Interim - 1 June 2026
Buyer: NHS England
End date in notice

Lupin Healthcare (UK) Limited

Published records by year

Buyer relationships by value counted

Published awards

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS National Branded Interim - 1 June 2026

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024

NHS National Generic Pharmaceuticals Wave 14b

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Antiretroviral Drugs

Proprietary Drugs

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

NP43325a Raltegravir

NP49425 Generic and Biosimilar Transition Medicines

Psychiatry and Neurology Medicines

Generic HIV Medicines

Oral Contraceptive Tablets